Important milestone towards public reimbursement for a new treatment option for eligible Canadian patients living with moderate to severe hidradenitis suppurativa (HS) Following this important milestone, Cosentyx has been listed… Read More
Vancouver (BC), Toronto (ON), and Montreal (QC) (July 9, 2025) — Canada has developed a world-class life sciences sector, but without stronger domestic investment, much of the economic value and intellectual… Read More
Dosing of the first patient in Phase 2b marks an important transition of the RESOLVE trial from a Phase 2a open-label study to a Phase 2b placebo-controlled study. This is… Read More
Companies to distribute First to Know® Syphilis Test kits at no cost to address rising infection rates across the country BURLINGTON, NC – Labcorp (NYSE: LH), a global leader of… Read More
VANCOUVER, BC – Acuitas Therapeutics announced the publication of a new study in Science Immunology, titled “An IL12 mRNA-LNP adjuvant enhances mRNA vaccine-induced CD8 T cell responses.” The study demonstrates… Read More
